Phibro Animal Health Corporation (PAHC) Revenue, Earnings & Financial Statements
$34.92NASDAQ: PAHCMarket Cap $1.42B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Phibro Animal Health Corporation most recently reported annual revenue of $1.5B, net profit of $100.0M. Revenue grew at an average annual rate of 12.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Phibro Animal Health Corporation: Revenue rose from $764.0M in 2017 to $1.5B in 2026, a change of +98.7% over 9 years; net profit was positive in all 10 reported years; operating margin was broadly flat at about 13.1%; the most recent year shows net profit of $100.0M.
Income Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Revenue
$764.0M
$820.0M
$828.0M
$800.0M
$833.0M
$942.0M
$978.0M
$1.0B
$1.3B
$1.5B
Operating Expenses
$666.0M
$721.0M
$755.0M
$731.0M
$758.0M
$863.0M
$906.0M
$964.0M
$1.2B
$1.3B
Operating Profit
$98.0M
$99.0M
$73.0M
$69.0M
$75.0M
$79.0M
$72.0M
$53.0M
$110.0M
$198.0M
Operating Margin
12.8%
12.1%
8.8%
8.7%
9.0%
8.4%
7.3%
5.2%
8.5%
13.1%
Other Income
−$17.0M
−$11.0M
−$12.0M
−$14.0M
−$8.0M
−$7.0M
−$18.0M
−$42.0M
−$42.0M
−$61.0M
Interest
$17.0M
$14.0M
$14.0M
$14.0M
$10.0M
$12.0M
$18.0M
$22.0M
$33.0M
$48.0M
Depreciation
$26.0M
$27.0M
$28.0M
$32.0M
$32.0M
$33.0M
$34.0M
$36.0M
$46.0M
$52.0M
Profit Before Tax
$81.0M
$88.0M
$72.0M
$56.0M
$66.0M
$72.0M
$54.0M
$11.0M
$68.0M
$137.0M
Tax rate (%)
19.8%
26.3%
23.5%
39.6%
18.2%
32.0%
39.7%
77.9%
29.0%
27.4%
Net Profit
$65.0M
$65.0M
$55.0M
$34.0M
$54.0M
$49.0M
$33.0M
$2.0M
$48.0M
$100.0M
EPS
$1.61
$1.61
$1.35
$0.83
$1.34
$1.21
$0.81
$0.06
$1.19
$2.44
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$250.0M
$263.0M
$273.0M
$260.0M
$309.0M
$348.0M
$379.0M
$364.0M
$374.0M
$384.0M
$397.0M
$387.0M
Operating Expenses
$234.0M
$243.0M
$255.0M
$243.0M
$284.0M
$314.0M
$345.0M
$316.0M
$319.0M
$336.0M
$349.0M
$337.0M
Operating Profit
$16.0M
$20.0M
$18.0M
$18.0M
$26.0M
$34.0M
$34.0M
$48.0M
$54.0M
$48.0M
$48.0M
$50.0M
Operating Margin
6.3%
7.6%
6.7%
6.8%
8.3%
9.6%
8.9%
13.2%
14.6%
12.5%
12.1%
12.8%
Interest
$9.0M
$9.0M
$6.0M
$8.0M
$9.0M
$13.0M
$8.0M
$13.0M
$13.0M
$11.0M
$10.0M
$11.0M
Profit Before Tax
$4.0M
$13.0M
$6.0M
$10.0M
$5.0M
$30.0M
$24.0M
$36.0M
$36.0M
$32.0M
$32.0M
$39.0M
Tax rate (%)
64.3%
35.0%
88.3%
27.5%
34.2%
29.7%
27.8%
26.9%
24.6%
25.6%
32.9%
23.9%
Net Profit
$1.0M
$8.0M
$1.0M
$7.0M
$3.0M
$21.0M
$17.0M
$27.0M
$27.0M
$24.0M
$22.0M
$30.0M
EPS
$0.03
$0.21
$0.02
$0.17
$0.08
$0.51
$0.42
$0.65
$0.67
$0.59
$0.53
$0.72
Over the 10 years reported for Phibro Animal Health Corporation, borrowings increased from $313.0M in 2017 to $789.0M in 2026, cash stood at $61.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.96 times.
Balance Sheet — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
$623.0M
$672.0M
$727.0M
$784.0M
$841.0M
$932.0M
$971.0M
$982.0M
$1.4B
$1.5B
Current Assets
$364.0M
$415.0M
$466.0M
$452.0M
$499.0M
$566.0M
$586.0M
$601.0M
$811.0M
$936.0M
Cash
$56.0M
$29.0M
$58.0M
$36.0M
$50.0M
$74.0M
$41.0M
$71.0M
$68.0M
$61.0M
Inventory
$161.0M
$178.0M
$198.0M
$197.0M
$216.0M
$259.0M
$278.0M
$266.0M
$444.0M
$535.0M
Receivables
$126.0M
$136.0M
$159.0M
$127.0M
$147.0M
$167.0M
$163.0M
$169.0M
$228.0M
$239.0M
Fixed Assets
$127.0M
$130.0M
$140.0M
$171.0M
$188.0M
$203.0M
$231.0M
$241.0M
$396.0M
$369.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$9.0M
$59.0M
$34.0M
$65.0M
$53.0M
$27.0M
$51.0M
$55.0M
$21.0M
$36.0M
Other Assets
$24.0M
$27.0M
$27.0M
$53.0M
$53.0M
$53.0M
$53.0M
$55.0M
$60.0M
$60.0M
Total Liabilities
$472.0M
$487.0M
$511.0M
$596.0M
$603.0M
$669.0M
$689.0M
$726.0M
$1.1B
$1.1B
Current Liabilities
$116.0M
$143.0M
$154.0M
$157.0M
$164.0M
$191.0M
$176.0M
$204.0M
$293.0M
$316.0M
Borrowings
$313.0M
$312.0M
$326.0M
$411.0M
$427.0M
$470.0M
$510.0M
$525.0M
$762.0M
$789.0M
Other Liabilities
$159.0M
$174.0M
$184.0M
$185.0M
$176.0M
$199.0M
$179.0M
$200.0M
$314.0M
$327.0M
Equity
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Reserves
$151.0M
$185.0M
$216.0M
$188.0M
$239.0M
$262.0M
$283.0M
$257.0M
$286.0M
$385.0M
For Phibro Animal Health Corporation, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $10.0M; free cash flow was positive in 8 of 10 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Operating Cash Flow
$98.0M
$70.0M
$47.0M
$59.0M
$48.0M
$32.0M
$13.0M
$88.0M
$80.0M
$69.0M
Investing Cash Flow
−$43.0M
−$103.0M
−$44.0M
−$154.0M
−$48.0M
−$60.0M
−$126.0M
−$89.0M
−$327.0M
−$131.0M
Financing Cash Flow
−$4.0M
$0
$0
$0
−$3.0M
−$5.0M
$4.0M
$0
−$9.0M
−$1.0M
Net Cash Flow
$22.0M
−$27.0M
$28.0M
−$21.0M
$14.0M
$24.0M
−$33.0M
$29.0M
−$3.0M
−$7.0M
Free Cash Flow
$78.0M
$51.0M
$17.0M
$25.0M
$19.0M
−$5.0M
−$38.0M
$46.0M
$42.0M
$10.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.27
EV / EBITDA
9.07
FCF Yield
1.51%
Quick Ratio
1.28
Interest Coverage
4.41
Return 1Y
-18.53%
Return 3Y
277.13%
Return 5Y
74.93%
Phibro Animal Health Corporation (PAHC) financials — frequently asked questions
What is Phibro Animal Health Corporation's annual revenue?
Phibro Animal Health Corporation (PAHC) reported annual revenue of $1.5B in its most recent fiscal year.
What is Phibro Animal Health Corporation's net profit?
Phibro Animal Health Corporation (PAHC) reported net profit of $100.0M in its most recent fiscal year.
What is PAHC EV/EBITDA?
Phibro Animal Health Corporation's enterprise value to EBITDA (EV/EBITDA) ratio is 9.07.
Revenue and earnings of other Drug Manufacturers - Specialty & Generic stocks